Potentiation of C1-esterase inhibitor by heparin and interactions with C1s protease as assessed by surface plasmon resonance

Biochimica et Biophysica Acta - General Subjects

Volumn 1820, Issue 1, 2012, Pages 56-63

  Rajabi, Mohsen ^a   Struble, Evi ^a   Zhou, Zhaohua ^b   Karnaukhova, Elena ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

C1 esterase inhibitor; C1s; Heparin; Surface plasmon resonance

Indexed keywords

COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C1S INHIBITOR; HEPARIN; SERINE PROTEINASE INHIBITOR;

ALPHA HELIX; ARTICLE; BETA SHEET; BINDING AFFINITY; BINDING KINETICS; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG POTENTIATION; DRUG PROTEIN BINDING; ENZYME ASSAY; HUMAN; ISOTHERM; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; SURFACE PLASMON RESONANCE;

COMPLEMENT C1 INHIBITOR PROTEIN; HEPARIN; HUMANS; SURFACE PLASMON RESONANCE;

EID: 81255173610     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2011.10.008     Document Type: Article

References (45)

1. B. Gooptu, and D.A. Lomas Conformational pathology of the serpins: themes, variations, and therapeutic strategies Annu. Rev. Biochem. 78 2009 147 176
2. G.A. Silverman, J.C. Whisstock, S.P. Bottomley, J.A. Huntington, D. Kaiserman, C.J. Luke, S.C. Pak, J.-M. Reichhart, and P.I. Bird Serpins flex their muscle. I. Putting the clamps on proteolysis in diverse biological systems J. Biol. Chem. 285 2010 24299 24305
3. A.E. Davis III, F. Lu, and P. Mejia C1 inhibitor, a multi-functional serine protease Inhibitor Thromb. Haemost. 104 2010 886 893
4. D. Wouters, I. Wagenaar-Bos, M. van Ham, and S. Zeerleder C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor Expert. Opin. Biol. Ther. 8 2008 1225 1240
5. F.S. Rosen, and A.E. Davis III Deficiency of C1 inhibitor Best Pract. Res. Clin. Gastroenterol. 19 2005 251 261
6. M.M. Frank Complement disorders and hereditary angioedema J. Allergy Clin. Immunol. 125 2010 S262 S271
7. A.E. Davis III, P. Mejia, and F. Lu Biological activities of C1 inhibitor Mol. Immunol. 45 2008 4057 4063
8. B.L. Zuraw Clinical practice. Hereditary angioedema N. Engl. J. Med. 359 2008 1027 1036
9. G.B. Caughman, R.J. Boackle, and J. Vesely A postulated mechanism for heparin's potentiation of C1 inhibitor function Mol. Immunol. 19 1982 287 295 (Pubitemid 12170414)
10. R.J. Boackle, G.B. Caughman, and J. Vesely Potentiation of factor H by heparin: a rate-limiting mechanism for inhibition of the alternative complement pathway Mol. Immunol. 20 1983 1157 1164 (Pubitemid 14230025)
11. W.A. Wuillemin, H. te Velthuis, Y.T. Lubbers, C.P. de Ruig, E. Eldering, and C.E. Hack Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma J. Immunol. 159 1997 1953 1960 (Pubitemid 127484185)
12. R. Rent, R. Eisenstein, and H. Gewurz Complement activation by interaction of polyanions and polycations. I. Heparin-protamine induced consumption of complement J. Immunol. 114 1975 120 124
13. B.A. Fiedel, R. Rent, R. Myhrman, and H. Gewurz Complement activation by interaction of polyanions and polycations. II. Precipitation and role of IgG, C1q and C1-INH during heparin-protamine-induced consumption of complement Immunology 30 1976 161 169
14. R.B. Sim, G.J. Arlaud, and M.G. Colomb Kinetics of reaction of human C1-inhibitor with the human complement system proteases C1r and C1s Biochim. Biophys. Acta 612 1980 433 449 (Pubitemid 10076173)
15. M. Lennick, S.A. Brew, and K.C. Ingham Kinetics of interaction of C1 inhibitor with complement C1s Biochemistry 25 1986 3890 3898 (Pubitemid 16042518)
16. E.E. Caldwell, A.M. Andreasen, M.A. Blietz, J.N. Serrahn, V. VanderNoot, Y. Park, G. Yu, R.J. Linhardt, and J.M. Weiler Heparin binding and augmentation of C1 inhibitor activity Arch. Biochem. Biophys. 361 1999 215 222 (Pubitemid 29391672)
17. I. Björk, S.T. Olson, and J.D. Shore Molecular mechanisms of the accelerating effect of heparin on the reactions between antithrombin and clotting proteinases D.A. Lane, U. Lindahl, Heparin: Chemical and Biological Properties, Clinical Applications 1989 Edward Arnold London 229 255
18. S.T. Olson, I. Björk, R. Sheffer, P.A. Craig, J.D. Shore, and I. Choay Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement J. Biol. Chem. 267 1992 12528 12538
19. V. Rossi, I. Bally, S. Ancelet, Y. Xu, V. Frémeaux-Bacchi, R.R. Vivès, R. Sadir, N. Thielens, and G.J. Arlaud Functional characterization of the recombinant human C1 inhibitor serpin domain: insights into heparin binding J. Immunol. 184 2010 4982 4989
20. H. Yu, E.M. Munoz, R.E. Edens, and R.J. Linhardt Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance Biochim. Biophys. Acta 1726 2005 168 176 (Pubitemid 41572256)
21. T. Nillson, and B. Wiman Purification and characterization of human C1-esterase Inhibitor Biochim. Biophys. Acta 705 1982 271 276
22. D.G. Myszka, and T.A. Morton CLAMP: a biosensor kinetic data analysis program Trends Biochem. Sci. 23 1998 149 150
23. D.J. Johnson, J. Langdown, and J.A. Huntington Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7 Å structure of the ternary complex Proc. Natl. Acad. Sci. U. S. A. 107 2010 645 650
24. S. Kim, J. Woo, E.J. Seo, M. Yu, and S. Ryu A 2.1 Angstrom structure of an uncleaved alpha(1)-antitrypsin shows variability of the reactive center and other loops J. Mol. Biol. 306 2001 109 119 (Pubitemid 33027736)
25. L. Beinrohr, V. Harmat, J. Dobó, Z. Lorincz, P. Gál, and P. Závodszky C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease J. Biol. Chem. 282 2007 21100 21109 (Pubitemid 47099924)
26. H. Hasegawa, and L. Holm Advances and pitfalls of protein structural alignment Curr. Opin. Struct. Biol. 19 2009 341 348
27. S. Munkvad, J. Jespersen, J. Gram, K. Overgaard, and M. Ranby Effects of methylamine and heparin on a rapid chromogenic assay of C1-esterase inhibitor in plasma Clin. Chem. 36 1990 737 741
28. I.G. Wagenaar-Bos, C. Drouet, E. Aygören-Pursun, K. Bork, C. Bucher, and A. Bygum Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations J. Immunol. Meth. 338 2008 14 20
29. T.A. Murray-Rust, F.K. Kerr, A.R. Thomas, T. Wu, T. Yongqing, P.C. Ong, N.S. Quinsey, J.C. Whisstock, I.C. Wagenaar-Bos, C. Freeman, and R.N. Pike Modulation of the proteolytic activity of the complement protease C1s by polyanions: implications for polyanion-mediated acceleration of interaction between C1s and SERPING1 Biochem. J. 422 2009 295 303
30. I.G. Bos, G.J. van Mierlo, W.K. Bleeker, G.M. Rigter, H. te Velthuis, G. Dickneite, and C.E. Hack The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model Int. Immunopharmacol. 1 2001 1583 1595 (Pubitemid 32622800)
31. L. Beinrohr, J. Dobó, P. Závodszky, and P. Gál C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation Trends Mol. Med. 14 2008 511 521
32. N. Sreerama, S.Y. Venyaminov, and R.W. Woody Estimation of protein secondary structure from circular dichroism spectra: Inclusion of denatured proteins with native proteins in the analysis Anal. Biochem. 287 2000 243 251 (Pubitemid 32006233)
33. N. Sreerama, and R.W. Woody Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set Anal. Biochem. 287 2000 252 260 (Pubitemid 32006234)
34. D.M. Rogers, and J.D. Hirst Calculations of protein circular dichroism from first principles Chirality 16 2004 234 243 (Pubitemid 38489975)
35. K. Matsuo, H. Namatame, M. Taniguchi, and K. Gekko Vacuum-ultraviolet circular dichroism analysis of glycosaminoglycans by synchrotron-radiation spectroscopy Biosci. Biotechnol. Biochem. 73 2009 557 561
36. T.R. Rudd, E.A. Yates, and M. Hricovíni Spectroscopic and theoretical approaches for the determination of heparin saccharide structure and the study of protein-glycos-aminoglycan complexes in solution Curr. Med. Chem. 16 2009 4750 4766
37. F.E. Stanley, and A.M. Stalcup The use of circular dichroism as a simple heparin- screening strategy Anal. Bioanal. Chem. 399 2011 701 706
38. L.A. Kuhn, J.H. Griffin, C.L. Fisher, J.S. Greengard, B.N. Bouma, F. España, and J.A. Tainer Elucidating the structural chemistry of glycosaminoglycan recognition by protein C inhibitor Proc. Natl. Acad. Sci. U. S. A. 87 1990 8506 8510
39. E. Wijelath, M. Namekata, J. Murray, M. Furuyashiki, S. Zhang, D. Coan, M. Wakao, R.B. Harris, Y. Suda, L. Wang, and M. Sobel Multiple mechanisms for exogenous heparin modulation of vascular endothelial growth factor activity J. Cell. Biochem. 111 2010 461 468
40. A.J. Gozzo, V.A. Nunes, I. Cruz-Silva, A.K. Carmona, H.B. Nader, A. Faljoni- Alario, M.U. Sampaio, and M.S. Araújo Heparin modulation of human plasma kallikrein on different substrates and inhibitors Biol. Chem. 387 2006 1129 1138 (Pubitemid 44200508)
41. A.L. Stone, D. Beeler, G. Oosta, and R.D. Rosenberg Circular dichroism spectroscopy of heparin-antithrombin interactions Proc. Natl. Acad. Sci. U. S. A. 79 1982 7190 7194 (Pubitemid 13190453)
42. N.S. Gandhi, and R.L. Mancera The structure of glycosaminoglycans and their interactions with proteins Chem. Biol. Drug Des. 72 2008 455 482
43. W. Li, D.J. Johnson, C.T. Esmon, and J.A. Huntington Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin Nat. Struct. Mol. Biol. 11 2004 857 862 (Pubitemid 39128802)
44. W. Li, and J.A. Huntington The heparin binding site of protein C inhibitor is protease-dependent J. Biol. Chem. 283 2008 36039 36045
45. V.K. Gupta, and L.R. Gowda Alpha-1-proteinase inhibitor is a heparin binding serpin: molecular interactions with the Lys rich cluster of helix-F domain Biochimie 90 2008 749 761